Home Healthcare IT Neurological Biomarkers Market Size, Trends and Growth Analysis Report 2031

Neurological Biomarkers Market Size, Share & Trends Analysis Report By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Applications (Alzheimer's Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End-User (Hospitals and Hospital Laboratories, Independent Clinical Diagnostic Centers, Research Organizations and Other) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54818DR
Last Updated : Feb 21, 2024
Author : Straits Research
Starting From
USD 1850
Buy Now

Market Segmentation

  1. Neurological Biomarkers Market, By Type (2021-2031)
    1. Genomic
    2. Proteomic
    3. Metabolomic
    4. Imaging
    5. Others
  2. Neurological Biomarkers Market, By Applications (2021-2031)
    1. Alzheimer's Disease
    2. Parkinson’s Disease
    3. Multiple Sclerosis
    4. Autism Spectrum Disorders
    5. Others
  3. Neurological Biomarkers Market, By End-User (2021-2031)
    1. Hospitals and Hospital Laboratories
    2. Independent Clinical Diagnostic Centers
    3. Research Organizations and Other
    1. North America
      1. North America Neurological Biomarkers Market, By Type
        1. Genomic
          1. Proteomic
            1. Metabolomic
              1. Imaging
                1. Others
                2. North America Neurological Biomarkers Market, By Applications
                  1. Alzheimer's Disease
                    1. Parkinson’s Disease
                      1. Multiple Sclerosis
                        1. Autism Spectrum Disorders
                          1. Others
                          2. North America Neurological Biomarkers Market, By End-User
                            1. Hospitals and Hospital Laboratories
                              1. Independent Clinical Diagnostic Centers
                                1. Research Organizations and Other
                                2. U.S.
                                  1. U.S. Neurological Biomarkers Market, By Type
                                    1. Genomic
                                      1. Proteomic
                                        1. Metabolomic
                                          1. Imaging
                                            1. Others
                                            2. U.S. Neurological Biomarkers Market, By Applications
                                              1. Alzheimer's Disease
                                                1. Parkinson’s Disease
                                                  1. Multiple Sclerosis
                                                    1. Autism Spectrum Disorders
                                                      1. Others
                                                      2. U.S. Neurological Biomarkers Market, By End-User
                                                        1. Hospitals and Hospital Laboratories
                                                          1. Independent Clinical Diagnostic Centers
                                                            1. Research Organizations and Other
                                                          2. Canada
                                                        2. Europe
                                                          1. Europe Neurological Biomarkers Market, By Type
                                                            1. Genomic
                                                              1. Proteomic
                                                                1. Metabolomic
                                                                  1. Imaging
                                                                    1. Others
                                                                    2. Europe Neurological Biomarkers Market, By Applications
                                                                      1. Alzheimer's Disease
                                                                        1. Parkinson’s Disease
                                                                          1. Multiple Sclerosis
                                                                            1. Autism Spectrum Disorders
                                                                              1. Others
                                                                              2. Europe Neurological Biomarkers Market, By End-User
                                                                                1. Hospitals and Hospital Laboratories
                                                                                  1. Independent Clinical Diagnostic Centers
                                                                                    1. Research Organizations and Other
                                                                                    2. U.K.
                                                                                      1. U.K. Neurological Biomarkers Market, By Type
                                                                                        1. Genomic
                                                                                          1. Proteomic
                                                                                            1. Metabolomic
                                                                                              1. Imaging
                                                                                                1. Others
                                                                                                2. U.K. Neurological Biomarkers Market, By Applications
                                                                                                  1. Alzheimer's Disease
                                                                                                    1. Parkinson’s Disease
                                                                                                      1. Multiple Sclerosis
                                                                                                        1. Autism Spectrum Disorders
                                                                                                          1. Others
                                                                                                          2. U.K. Neurological Biomarkers Market, By End-User
                                                                                                            1. Hospitals and Hospital Laboratories
                                                                                                              1. Independent Clinical Diagnostic Centers
                                                                                                                1. Research Organizations and Other
                                                                                                              2. Germany
                                                                                                              3. France
                                                                                                              4. Spain
                                                                                                              5. Italy
                                                                                                              6. Russia
                                                                                                              7. Nordic
                                                                                                              8. Benelux
                                                                                                              9. Rest of Europe
                                                                                                            2. APAC
                                                                                                              1. APAC Neurological Biomarkers Market, By Type
                                                                                                                1. Genomic
                                                                                                                  1. Proteomic
                                                                                                                    1. Metabolomic
                                                                                                                      1. Imaging
                                                                                                                        1. Others
                                                                                                                        2. APAC Neurological Biomarkers Market, By Applications
                                                                                                                          1. Alzheimer's Disease
                                                                                                                            1. Parkinson’s Disease
                                                                                                                              1. Multiple Sclerosis
                                                                                                                                1. Autism Spectrum Disorders
                                                                                                                                  1. Others
                                                                                                                                  2. APAC Neurological Biomarkers Market, By End-User
                                                                                                                                    1. Hospitals and Hospital Laboratories
                                                                                                                                      1. Independent Clinical Diagnostic Centers
                                                                                                                                        1. Research Organizations and Other
                                                                                                                                        2. China
                                                                                                                                          1. China Neurological Biomarkers Market, By Type
                                                                                                                                            1. Genomic
                                                                                                                                              1. Proteomic
                                                                                                                                                1. Metabolomic
                                                                                                                                                  1. Imaging
                                                                                                                                                    1. Others
                                                                                                                                                    2. China Neurological Biomarkers Market, By Applications
                                                                                                                                                      1. Alzheimer's Disease
                                                                                                                                                        1. Parkinson’s Disease
                                                                                                                                                          1. Multiple Sclerosis
                                                                                                                                                            1. Autism Spectrum Disorders
                                                                                                                                                              1. Others
                                                                                                                                                              2. China Neurological Biomarkers Market, By End-User
                                                                                                                                                                1. Hospitals and Hospital Laboratories
                                                                                                                                                                  1. Independent Clinical Diagnostic Centers
                                                                                                                                                                    1. Research Organizations and Other
                                                                                                                                                                  2. Korea
                                                                                                                                                                  3. Japan
                                                                                                                                                                  4. India
                                                                                                                                                                  5. Australia
                                                                                                                                                                  6. Taiwan
                                                                                                                                                                  7. South East Asia
                                                                                                                                                                  8. Rest of Asia-Pacific
                                                                                                                                                                2. Middle East and Africa
                                                                                                                                                                  1. Middle East and Africa Neurological Biomarkers Market, By Type
                                                                                                                                                                    1. Genomic
                                                                                                                                                                      1. Proteomic
                                                                                                                                                                        1. Metabolomic
                                                                                                                                                                          1. Imaging
                                                                                                                                                                            1. Others
                                                                                                                                                                            2. Middle East and Africa Neurological Biomarkers Market, By Applications
                                                                                                                                                                              1. Alzheimer's Disease
                                                                                                                                                                                1. Parkinson’s Disease
                                                                                                                                                                                  1. Multiple Sclerosis
                                                                                                                                                                                    1. Autism Spectrum Disorders
                                                                                                                                                                                      1. Others
                                                                                                                                                                                      2. Middle East and Africa Neurological Biomarkers Market, By End-User
                                                                                                                                                                                        1. Hospitals and Hospital Laboratories
                                                                                                                                                                                          1. Independent Clinical Diagnostic Centers
                                                                                                                                                                                            1. Research Organizations and Other
                                                                                                                                                                                            2. UAE
                                                                                                                                                                                              1. UAE Neurological Biomarkers Market, By Type
                                                                                                                                                                                                1. Genomic
                                                                                                                                                                                                  1. Proteomic
                                                                                                                                                                                                    1. Metabolomic
                                                                                                                                                                                                      1. Imaging
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                        2. UAE Neurological Biomarkers Market, By Applications
                                                                                                                                                                                                          1. Alzheimer's Disease
                                                                                                                                                                                                            1. Parkinson’s Disease
                                                                                                                                                                                                              1. Multiple Sclerosis
                                                                                                                                                                                                                1. Autism Spectrum Disorders
                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                  2. UAE Neurological Biomarkers Market, By End-User
                                                                                                                                                                                                                    1. Hospitals and Hospital Laboratories
                                                                                                                                                                                                                      1. Independent Clinical Diagnostic Centers
                                                                                                                                                                                                                        1. Research Organizations and Other
                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                      1. LATAM Neurological Biomarkers Market, By Type
                                                                                                                                                                                                                        1. Genomic
                                                                                                                                                                                                                          1. Proteomic
                                                                                                                                                                                                                            1. Metabolomic
                                                                                                                                                                                                                              1. Imaging
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                2. LATAM Neurological Biomarkers Market, By Applications
                                                                                                                                                                                                                                  1. Alzheimer's Disease
                                                                                                                                                                                                                                    1. Parkinson’s Disease
                                                                                                                                                                                                                                      1. Multiple Sclerosis
                                                                                                                                                                                                                                        1. Autism Spectrum Disorders
                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                          2. LATAM Neurological Biomarkers Market, By End-User
                                                                                                                                                                                                                                            1. Hospitals and Hospital Laboratories
                                                                                                                                                                                                                                              1. Independent Clinical Diagnostic Centers
                                                                                                                                                                                                                                                1. Research Organizations and Other
                                                                                                                                                                                                                                                2. Brazil
                                                                                                                                                                                                                                                  1. Brazil Neurological Biomarkers Market, By Type
                                                                                                                                                                                                                                                    1. Genomic
                                                                                                                                                                                                                                                      1. Proteomic
                                                                                                                                                                                                                                                        1. Metabolomic
                                                                                                                                                                                                                                                          1. Imaging
                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                            2. Brazil Neurological Biomarkers Market, By Applications
                                                                                                                                                                                                                                                              1. Alzheimer's Disease
                                                                                                                                                                                                                                                                1. Parkinson’s Disease
                                                                                                                                                                                                                                                                  1. Multiple Sclerosis
                                                                                                                                                                                                                                                                    1. Autism Spectrum Disorders
                                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                                      2. Brazil Neurological Biomarkers Market, By End-User
                                                                                                                                                                                                                                                                        1. Hospitals and Hospital Laboratories
                                                                                                                                                                                                                                                                          1. Independent Clinical Diagnostic Centers
                                                                                                                                                                                                                                                                            1. Research Organizations and Other
                                                                                                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                                                                                                          4. Chile
                                                                                                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                                                                                                      Related Reports

                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      Digital Biomarkers Market Size The global digital biomarkers market size was valued at USD 3.43 billion in 2023 and is projected to reach USD 49.17 billion by 2032, growing at a CAGR of 34.43% during the forecast period (2024–2032). In recent years,
                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global renal biomarkers market size was valued at USD 1,119.82 million in 2022. It is estimated to reach USD 2,158.11 million by 2031, growing at a CAGR of 7.56% during the forecast period (2023–2031). Biomarkers are substances that c
                                                                                                                                                                                                                                                                      Buy Now

                                                                                                                                                                                                                                                                      Purchase Benefits

                                                                                                                                                                                                                                                                      • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                      • Completely customizable scope
                                                                                                                                                                                                                                                                      • 30% discount on your next purchase
                                                                                                                                                                                                                                                                      • Dedicated account manager
                                                                                                                                                                                                                                                                      • Query resolution within 24 hours
                                                                                                                                                                                                                                                                      • Permission to print the report


                                                                                                                                                                                                                                                                      We are featured on :